[PRESS RELEASE] – EDMONTON, Alberta, Feb. 20, 2025 – Aurora Hashish Inc., the Canadian-based main world clinical hashish corporate, introduced the corporate’s prolonged pastille choices in Australia. This growth marks some other significant step in Aurora’s deep dedication to providing sufferers a various vary of fine quality, top rate clinical hashish merchandise to satisfy their quite a lot of wishes and pursuits.
“Increasing our portfolio of clinical hashish pastilles in Australia demonstrates our working out of marketplace call for and is some other instance of our talent to convey fine quality product to this key marketplace as affected person hobby will increase,” stated Andre Jerome, govt vp of International Trade Building at Aurora. “On this swiftly increasing marketplace, we are leveraging our distinctive features, together with world production and excellence in navigating regulatory frameworks that outline Aurora’s management.”
Clinical hashish pastilles be offering a number of key advantages, together with simple oral consumption. The extended results supply long-lasting and prolonged aid after digestion. Pastilles additionally are available in an out there structure this is discrete, moveable, and handy.
The pastilles that are actually to be had in Australia come with:
- Aurora Pastilles – 10mg THC Pomegranate Berry (30 pack)
- Aurora Pastilles – 10:10 Balanced Pineapple (30 pack)
- Aurora Pastilles – 25mg CBD Acai Berry (30 pack)
Aurora maintains its place as the biggest world clinical hashish corporate running in nationally criminal markets. The corporate has a strong innovation pipeline deliberate for world creation over the approaching months, bringing selection and new choices to sufferers.
